Stock Earnings Analyzing Verve Therapeutics Inc (VERV) After Recent Trading Activity Verve Therapeutics Inc’s filing revealed that its Chief Executive Officer Kathiresan Sekar unloaded Company’s shares for reported $40761.0 on Apr
Insiders Updates Cantor Fitzgerald gives an Overweight recommendation for Verve Therapeutics Inc (VERV) Verve Therapeutics Inc’s recent filing unveils that its Chief Executive Officer Kathiresan Sekar unloaded Company’s shares for reported $40761.0 on
Stock Earnings VERV’s latest rating updates from top analysts. Verve Therapeutics Inc’s filing revealed that its Chief Executive Officer Kathiresan Sekar unloaded Company’s shares for reported $40761.0 on Apr
Analyzing Stock On Your Own: Verve Therapeutics Inc. (NASDAQ: VERV) Verve Therapeutics Inc. (NASDAQ:VERV) does about 768.12K shares in volume on a normal day but saw 618802 shares change hands